Company / PP&E (Net)
Biohaven Ltd. PP&E (Net) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$17.3M
FY2024
5-year range
$13.0M / $17.5M
FY2021-FY2024
Trend
+0.8%
vs FY2023
Sector context
#82 of 193
Health Care
What the data says
At $17M, Biohaven Ltd.'s pp&e (net) ranks #82 of 193 in the Health Care sector.
Based on SEC 10-K filings.
$17M in FY2024 with a 3-year CAGR of +10.0%.
Remained stable around $17M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#82 of 193 in Health CareTop 42% of 193This company $17.3M Sector average $777.6M
▼
-97.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +10.0%, indicating consistent growth.
- In FY2024, pp&e (net) increased 0.8% year-over-year.
- Ranks #82 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $17.3M | +0.8% |
| FY2023 | $17.2M | -1.8% |
| FY2022 | $17.5M | +34.6% |
| FY2021 | $13.0M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026